Gremubamab
Modify Date: 2024-04-02 19:44:15
Gremubamab structure
|
Common Name | Gremubamab | ||
|---|---|---|---|---|
| CAS Number | 1800381-36-5 | Molecular Weight | N/A | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | N/A | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of GremubamabGremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections[1][2]. |
| Name | Gremubamab |
|---|
| Description | Gremubamab (MEDI3902) is a humanized IgG1 kappa anti-PcrV/Psl monoclonal antibody. Gremubamab binds to the PA PcrV protein and Psl exopolysaccharide. Gremubamab has the potential for the research of pseudomonas aeruginosa infections[1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Gremubamab (1, 5, 15 mg/kg; i.v.; at 1 h postinfection) 改善兔急性肺炎模型的生存结果[2]。 Animal Model: Rabbits (acute pneumonia model)[2] Dosage: 1, 5, 15 mg/kg Administration: I.v.; at 1 h postinfection Result: Improved survival outcomes in a dose-dependent manner in a rabbit acute pneumonia model. |
| References |
| No Any Chemical & Physical Properties |